APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nociceptin Receptor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nociceptin Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174017440322 December 2025185 pages

Choose your research edition.

Industry ResearchNociceptin Receptor Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Nociceptin Receptor Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Nociceptin Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nociceptin Receptor Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Nociceptin Receptor Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Nociceptin Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nociceptin Receptor include Serodus ASA, Orexigen Therapeutics Inc, Grunenthal GmbH, Fuso Pharmaceutical Industries Ltd and Blackthorn Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nociceptin Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nociceptin Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nociceptin Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nociceptin Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Nociceptin Receptor Segment by Company

Serodus ASA

Orexigen Therapeutics Inc

Grunenthal GmbH

Fuso Pharmaceutical Industries Ltd

Blackthorn Therapeutics Inc

Nociceptin Receptor Segment by Type

GRTTA-2210

GRT-6010

Cebranopadol

BTRX-246040

AT-403

Others

Nociceptin Receptor Segment by Application

Major Depressive Disorder

Drug Addiction

Diabetic Neuropathic Pain

Postherpetic Neuralgia

Others

Nociceptin Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nociceptin Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nociceptin Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nociceptin Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nociceptin Receptor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nociceptin Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nociceptin Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nociceptin Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nociceptin Receptor Industry Trends Table 2. Nociceptin Receptor Industry Drivers Table 3. Nociceptin Receptor Industry Opportunities and Challenges Table 4. Nociceptin Receptor Industry Restraints Table 5. Global Nociceptin Receptor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nociceptin Receptor Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nociceptin Receptor Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Nociceptin Receptor Sales Market Share by Manufacturers Table 9. Global Nociceptin Receptor Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Nociceptin Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nociceptin Receptor Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nociceptin Receptor Manufacturers, Product Type & Application Table 13. Global Nociceptin Receptor Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nociceptin Receptor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of GRTTA-2210 Table 17. Major Manufacturers of GRT-6010 Table 18. Major Manufacturers of Cebranopadol Table 19. Major Manufacturers of BTRX-246040 Table 20. Major Manufacturers of AT-403 Table 21. Major Manufacturers of Others Table 22. Global Nociceptin Receptor Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 24. Global Nociceptin Receptor Sales by Type (2027-2032) & (k units) Table 25. Global Nociceptin Receptor Sales Market Share by Type (2021-2026) Table 26. Global Nociceptin Receptor Sales Market Share by Type (2027-2032) Table 27. Global Nociceptin Receptor Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Nociceptin Receptor Revenue by Type (2021-2026) & (k units) Table 29. Global Nociceptin Receptor Revenue by Type (2027-2032) & (k units) Table 30. Global Nociceptin Receptor Revenue Market Share by Type (2021-2026) Table 31. Global Nociceptin Receptor Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Major Depressive Disorder Table 33. Major Manufacturers of Drug Addiction Table 34. Major Manufacturers of Diabetic Neuropathic Pain Table 35. Major Manufacturers of Postherpetic Neuralgia Table 36. Major Manufacturers of Others Table 37. Global Nociceptin Receptor Sales by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 39. Global Nociceptin Receptor Sales by Application (2027-2032) & (k units) Table 40. Global Nociceptin Receptor Sales Market Share by Application (2021-2026) Table 41. Global Nociceptin Receptor Sales Market Share by Application (2027-2032) Table 42. Global Nociceptin Receptor Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 43. Global Nociceptin Receptor Revenue by Application (2021-2026) & (k units) Table 44. Global Nociceptin Receptor Revenue by Application (2027-2032) & (k units) Table 45. Global Nociceptin Receptor Revenue Market Share by Application (2021-2026) Table 46. Global Nociceptin Receptor Revenue Market Share by Application (2027-2032) Table 47. Global Nociceptin Receptor Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Nociceptin Receptor Sales by Region (2021-2026) & (k units) Table 49. Global Nociceptin Receptor Sales Market Share by Region (2021-2026) Table 50. Global Nociceptin Receptor Sales Forecasted by Region (2027-2032) & (k units) Table 51. Global Nociceptin Receptor Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Nociceptin Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. North America Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 54. North America Nociceptin Receptor Sales by Country (2027-2032) & (k units) Table 55. Europe Nociceptin Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Europe Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 57. Europe Nociceptin Receptor Sales by Country (2027-2032) & (k units) Table 58. Asia Pacific Nociceptin Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Asia Pacific Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 60. Asia Pacific Nociceptin Receptor Sales by Country (2027-2032) & (k units) Table 61. South America, Middle East and Africa Nociceptin Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 62. South America, Middle East and Africa Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 63. South America, Middle East and Africa Nociceptin Receptor Sales by Country (2027-2032) & (k units) Table 64. Global Nociceptin Receptor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Nociceptin Receptor Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Nociceptin Receptor Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Nociceptin Receptor Revenue Market Share by Region (2021-2026) Table 68. Global Nociceptin Receptor Revenue Market Share by Region (2027-2032) Table 69. Serodus ASA Company Information Table 70. Serodus ASA Business Overview Table 71. Serodus ASA Nociceptin Receptor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Serodus ASA Nociceptin Receptor Product Portfolio Table 73. Serodus ASA Recent Development Table 74. Orexigen Therapeutics Inc Company Information Table 75. Orexigen Therapeutics Inc Business Overview Table 76. Orexigen Therapeutics Inc Nociceptin Receptor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Orexigen Therapeutics Inc Nociceptin Receptor Product Portfolio Table 78. Orexigen Therapeutics Inc Recent Development Table 79. Grunenthal GmbH Company Information Table 80. Grunenthal GmbH Business Overview Table 81. Grunenthal GmbH Nociceptin Receptor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Grunenthal GmbH Nociceptin Receptor Product Portfolio Table 83. Grunenthal GmbH Recent Development Table 84. Fuso Pharmaceutical Industries Ltd Company Information Table 85. Fuso Pharmaceutical Industries Ltd Business Overview Table 86. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product Portfolio Table 88. Fuso Pharmaceutical Industries Ltd Recent Development Table 89. Blackthorn Therapeutics Inc Company Information Table 90. Blackthorn Therapeutics Inc Business Overview Table 91. Blackthorn Therapeutics Inc Nociceptin Receptor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Blackthorn Therapeutics Inc Nociceptin Receptor Product Portfolio Table 93. Blackthorn Therapeutics Inc Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Nociceptin Receptor Distributors List Table 97. Nociceptin Receptor Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Nociceptin Receptor Product Image Figure 2. Global Nociceptin Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nociceptin Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Nociceptin Receptor Sales (2021-2032) & (k units) Figure 5. Global Nociceptin Receptor Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Nociceptin Receptor Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. GRTTA-2210 Image Figure 9. GRT-6010 Image Figure 10. Cebranopadol Image Figure 11. BTRX-246040 Image Figure 12. AT-403 Image Figure 13. Others Image Figure 14. Global Nociceptin Receptor Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Nociceptin Receptor Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Nociceptin Receptor Sales Market Share by Type (2021-2032) Figure 17. Global Nociceptin Receptor Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Nociceptin Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Nociceptin Receptor Revenue Market Share by Type (2021-2032) Figure 20. Major Depressive Disorder Image Figure 21. Drug Addiction Image Figure 22. Diabetic Neuropathic Pain Image Figure 23. Postherpetic Neuralgia Image Figure 24. Others Image Figure 25. Global Nociceptin Receptor Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Nociceptin Receptor Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Nociceptin Receptor Sales Market Share by Application (2021-2032) Figure 28. Global Nociceptin Receptor Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 29. Global Nociceptin Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Nociceptin Receptor Revenue Market Share by Application (2021-2032) Figure 31. North America Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 32. North America Nociceptin Receptor Sales Market Share by Country (2021-2032) Figure 33. U.S. Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 34. Canada Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 35. Mexico Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 37. Europe Nociceptin Receptor Sales Market Share by Country (2021-2032) Figure 38. Germany Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 39. France Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 40. U.K. Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 41. Italy Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 42. Netherlands Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 44. Asia Pacific Nociceptin Receptor Sales Market Share by Country (2021-2032) Figure 45. China Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 46. Japan Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Korea Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 48. Southeast Asia Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 49. India Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 50. Australia Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 52. South America, Middle East and Africa Nociceptin Receptor Sales Market Share by Country (2021-2032) Figure 53. Brazil Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 54. South Africa Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 55. Saudi Arabia Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 56. Turkey Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 57. Argentina Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 58. UAE Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 59. Egypt Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 60. Chile Nociceptin Receptor Sales and Growth Rate (2021-2032) & (k units) Figure 61. Global Nociceptin Receptor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Nociceptin Receptor Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Figure 64. North America Nociceptin Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Figure 66. Europe Nociceptin Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Nociceptin Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Nociceptin Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Nociceptin Receptor Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Nociceptin Receptor Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • GRTTA-2210
  • GRT-6010
  • Cebranopadol
  • BTRX-246040
  • AT-403
  • Others
Applications
  • Major Depressive Disorder
  • Drug Addiction
  • Diabetic Neuropathic Pain
  • Postherpetic Neuralgia
  • Others
Companies covered
  • Serodus ASA
  • Orexigen Therapeutics Inc
  • Grunenthal GmbH
  • Fuso Pharmaceutical Industries Ltd
  • Blackthorn Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nociceptin Receptor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nociceptin Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nociceptin Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nociceptin Receptor Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nociceptin Receptor Market Dynamics
  1. 2.1 Nociceptin Receptor Industry Trends
  2. 2.2 Nociceptin Receptor Industry Drivers
  3. 2.3 Nociceptin Receptor Industry Opportunities and Challenges
  4. 2.4 Nociceptin Receptor Industry Restraints
3 Nociceptin Receptor Market by Manufacturers
  1. 3.1 Global Nociceptin Receptor Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nociceptin Receptor Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nociceptin Receptor Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nociceptin Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nociceptin Receptor Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nociceptin Receptor Manufacturers, Product Type & Application
  7. 3.7 Global Nociceptin Receptor Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nociceptin Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nociceptin Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nociceptin Receptor Tier 1, Tier 2, and Tier 3
4 Nociceptin Receptor Market by Type
  1. 4.1 Nociceptin Receptor Type Introduction
  2. 4.1.1 GRTTA-2210
  3. 4.1.2 GRT-6010
  4. 4.1.3 Cebranopadol
  5. 4.1.4 BTRX-246040
  6. 4.1.5 AT-403
  7. 4.1.6 Others
  8. 4.2 Global Nociceptin Receptor Sales by Type
  9. 4.2.1 Global Nociceptin Receptor Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Nociceptin Receptor Sales by Type (2021-2032)
  11. 4.2.3 Global Nociceptin Receptor Sales Market Share by Type (2021-2032)
  12. 4.3 Global Nociceptin Receptor Revenue by Type
  13. 4.3.1 Global Nociceptin Receptor Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Nociceptin Receptor Revenue by Type (2021-2032)
  15. 4.3.3 Global Nociceptin Receptor Revenue Market Share by Type (2021-2032)
5 Nociceptin Receptor Market by Application
  1. 5.1 Nociceptin Receptor Application Introduction
  2. 5.1.1 Major Depressive Disorder
  3. 5.1.2 Drug Addiction
  4. 5.1.3 Diabetic Neuropathic Pain
  5. 5.1.4 Postherpetic Neuralgia
  6. 5.1.5 Others
  7. 5.2 Global Nociceptin Receptor Sales by Application
  8. 5.2.1 Global Nociceptin Receptor Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Nociceptin Receptor Sales by Application (2021-2032)
  10. 5.2.3 Global Nociceptin Receptor Sales Market Share by Application (2021-2032)
  11. 5.3 Global Nociceptin Receptor Revenue by Application
  12. 5.3.1 Global Nociceptin Receptor Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Nociceptin Receptor Revenue by Application (2021-2032)
  14. 5.3.3 Global Nociceptin Receptor Revenue Market Share by Application (2021-2032)
6 Global Nociceptin Receptor Sales by Region
  1. 6.1 Global Nociceptin Receptor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nociceptin Receptor Sales by Region (2021-2032)
  3. 6.2.1 Global Nociceptin Receptor Sales by Region (2021-2026)
  4. 6.2.2 Global Nociceptin Receptor Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nociceptin Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nociceptin Receptor Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nociceptin Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nociceptin Receptor Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nociceptin Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nociceptin Receptor Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nociceptin Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nociceptin Receptor Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nociceptin Receptor Revenue by Region
  1. 7.1 Global Nociceptin Receptor Revenue by Region
  2. 7.1.1 Global Nociceptin Receptor Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nociceptin Receptor Revenue by Region (2021-2026)
  4. 7.1.3 Global Nociceptin Receptor Revenue by Region (2027-2032)
  5. 7.1.4 Global Nociceptin Receptor Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nociceptin Receptor Revenue (2021-2032)
  8. 7.2.2 North America Nociceptin Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nociceptin Receptor Revenue (2021-2032)
  11. 7.3.2 Europe Nociceptin Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nociceptin Receptor Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nociceptin Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nociceptin Receptor Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nociceptin Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Serodus ASA
  2. 8.1.1 Serodus ASA Company Information
  3. 8.1.2 Serodus ASA Business Overview
  4. 8.1.3 Serodus ASA Nociceptin Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Serodus ASA Nociceptin Receptor Product Portfolio
  6. 8.1.5 Serodus ASA Recent Developments
  7. 8.2 Orexigen Therapeutics Inc
  8. 8.2.1 Orexigen Therapeutics Inc Company Information
  9. 8.2.2 Orexigen Therapeutics Inc Business Overview
  10. 8.2.3 Orexigen Therapeutics Inc Nociceptin Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Orexigen Therapeutics Inc Nociceptin Receptor Product Portfolio
  12. 8.2.5 Orexigen Therapeutics Inc Recent Developments
  13. 8.3 Grunenthal GmbH
  14. 8.3.1 Grunenthal GmbH Company Information
  15. 8.3.2 Grunenthal GmbH Business Overview
  16. 8.3.3 Grunenthal GmbH Nociceptin Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grunenthal GmbH Nociceptin Receptor Product Portfolio
  18. 8.3.5 Grunenthal GmbH Recent Developments
  19. 8.4 Fuso Pharmaceutical Industries Ltd
  20. 8.4.1 Fuso Pharmaceutical Industries Ltd Company Information
  21. 8.4.2 Fuso Pharmaceutical Industries Ltd Business Overview
  22. 8.4.3 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product Portfolio
  24. 8.4.5 Fuso Pharmaceutical Industries Ltd Recent Developments
  25. 8.5 Blackthorn Therapeutics Inc
  26. 8.5.1 Blackthorn Therapeutics Inc Company Information
  27. 8.5.2 Blackthorn Therapeutics Inc Business Overview
  28. 8.5.3 Blackthorn Therapeutics Inc Nociceptin Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Blackthorn Therapeutics Inc Nociceptin Receptor Product Portfolio
  30. 8.5.5 Blackthorn Therapeutics Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nociceptin Receptor Value Chain Analysis
  2. 9.1.1 Nociceptin Receptor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nociceptin Receptor Production Mode & Process
  6. 9.2 Nociceptin Receptor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nociceptin Receptor Distributors
  9. 9.2.3 Nociceptin Receptor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst